Medical Device | March 10, 2026
Codis expands UK manufacturing with groundbreaking spray dryer
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
The new equipment will be installed at Codis’ 400,000-square-foot Haverhill facility and is expected to be operational by 2027
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Better serving global partners and advancing healthcare innovation
Subscribe To Our Newsletter & Stay Updated
